(top 60%)
Impact Factor
(top 60%)
extended IF
43(top 9%)
H-Index
251
authors
413
papers
8K
citations
1.7K
citing journals
5.3K
citing authors

Most Cited Articles of The Hematology Journal

TitleYearCitations
Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation2003317
Biallelic mutations in the CEBPA gene and low CEBPA expression levels as prognostic markers in intermediate-risk AML2003182
The effect of iron deficiency anemia on the function of the immune system2005160
Mesenchymal stem cell: use and perspectives2003145
Pulsed cyclophosphamide, thalidomide and dexamethasone: an oral regimen for previously treated patients with multiple myeloma2004117
Efficacy of low-dose thalidomide and dexamethasone as first salvage regimen in multiple myeloma2004111
Phase II trial of arsenic trioxide and alpha interferon in patients with relapsed/refractory adult T-cell leukemia/lymphoma2004110
Female donors influence transplant-related mortality and relapse incidence in male recipients of sibling blood and marrow transplants2001110
The 5TMM series: a useful in vivo mouse model of human multiple myeloma2000102
High incidence of BCR-ABL kinase domain mutations and absence of mutations of the PDGFR and KIT activation loops in CML patients with secondary resistance to imatinib2004100
A prospective phase II clinical trial with the use of zidovudine and interferon-alpha in the acute and lymphoma forms of adult T-cell leukemia/lymphoma200289
XIAP expression correlates with monocytic differentiation in adult de novo AML: impact on prognosis200488
Are myeloma patients with renal failure candidates for autologous stem cell transplantation?200086
Overwhelming postsplenectomy infection: is quality of patient knowledge enough for prevention?200485
Gp130 and ras mediated signaling in human plasma cell line INA-6: a cytokine-regulated tumor model for plasmacytoma200184
Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation200380
Tumor necrosis factor alpha release is a major biological event associated with rituximab treatment200177
A prospective comparison of fine-needle aspiration cytology and histopathology in the diagnosis and classification of lymphomas200475
Factors which predict unsuccessful mobilisation of peripheral blood progenitor cells following G-CSF alone in patients with non-Hodgkin's lymphoma200075
Patterns of mortality in sickle cell disease in adults in France and England200274
Role of coagulation testing in predicting bleeding risk200371
A clinical, molecular and cytogenetic study of 12 cases of human herpesvirus 8 associated primary effusion lymphoma in HIV-infected patients200170
Variability in B-cell antigen expression: implications for the treatment of B-cell lymphomas and leukemias with monoclonal antibodies200167
Thalidomide in patients with advanced multiple myeloma: a study of 83 patients--report of the Intergroupe Francophone du Myélome (IFM)200261
Nuclear transplantation, embryonic stem cells and the potential for cell therapy200459